Cumberland Pharmaceuticals, Inc. (CPIX)
6.62
-0.17
(-2.50%)
USD |
NASDAQ |
Sep 08, 16:00
6.80
+0.18
(+2.72%)
After-Hours: 07:34
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 99.19M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 141.8% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 3.168 |
| Price to Book Value | 5.688 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 1.50 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.2703 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 84.73% |
Profile
| Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which focuses on the acquisition, development, and commercialization of branded prescription pharmaceutical products. Its products include Acetadote, Caldolor, Kristalose, Omeclamox, Vaprisol, Vibativ, Sancuso, Boxaban, Vasculan. Dyscorban, and RediTrex. The company was founded by A. J. Kazimi on January 7, 1999 and is headquartered in Nashville, TN. |
| URL | http://www.cumberlandpharma.com |
| Investor Relations URL | http://investor.shareholder.com/cpix/ |
| HQ State/Province | Tennessee |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Small Cap Value |
| Next Earnings Release | Nov. 03, 2026 (est.) |
| Last Earnings Release | Aug. 04, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Aug. 03, 2026 |
Profile
| Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which focuses on the acquisition, development, and commercialization of branded prescription pharmaceutical products. Its products include Acetadote, Caldolor, Kristalose, Omeclamox, Vaprisol, Vibativ, Sancuso, Boxaban, Vasculan. Dyscorban, and RediTrex. The company was founded by A. J. Kazimi on January 7, 1999 and is headquartered in Nashville, TN. |
| URL | http://www.cumberlandpharma.com |
| Investor Relations URL | http://investor.shareholder.com/cpix/ |
| HQ State/Province | Tennessee |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Small Cap Value |
| Next Earnings Release | Nov. 03, 2026 (est.) |
| Last Earnings Release | Aug. 04, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Aug. 03, 2026 |